tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
PremiumThe FlyH.C. Wainwright remains bullish on Xoma following creative Takeda deal
2M ago
XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
Premium
Ratings
XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
2M ago
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
Premium
The Fly
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
2M ago
Xoma to acquire Generation Bio for $4.2913 per share
PremiumThe FlyXoma to acquire Generation Bio for $4.2913 per share
2M ago
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
Premium
Ratings
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
2M ago
Xoma price target lowered to $97 from $104 at H.C. Wainwright
Premium
The Fly
Xoma price target lowered to $97 from $104 at H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100